23580-89-4,
N-methyl-3-phenylpropan-1-amine,
(3-Phenylpropyl)methylamine,
Methyl-(3-phenyl-propyl)-amine,
methyl(3-phenylpropyl)amine,
N-Methyl-3-phenylpropylamine,
N-methyl-N-(3-phenylpropyl)amine,
BENZENEPROPANAMINE, N-METHYL-,
MLS000529568,
SMR000122043,
AC1L1TO9,
Benzenepropanamine,N-methyl-,
SCHEMBL21677,
N-Methylbenzenepropan-1-amine,
AC1Q419X,
CHEMBL301755,
BDBM32703,
cid_9549628,
CTK4F1828,
DTXSID90275301,
(3-phenylpropan-1-yl)methylamine,
MLHBZVFOTDJTPK-UHFFFAOYSA-N,
N-METHYL-BENZENEPROPANAMINE,
HMS1695L10,
1-(N-methylamino)-3-phenylpropane,
3AMA-0-0,
ACT10864,
KS-000029ZC,
ZINC1684599,
1600AB,
ANW-65998,
AR1442,
SBB010169,
AKOS000156252,
AB10671,
MCULE-5668199111,
PS-3586,
TRA0057720,
(3-phenylpropyl)methylamine, AldrichCPR,
methyl(3-phenylpropyl)amine;hydrochloride,
NCGC00245431-01,
AJ-29804,
BAS 09614940,
BP-11151,
SC-92122,
DB-046188,
TR-010938,
FT-0638335,
ST24048638,
ST50287647,
EN300-40932,
N-methyl-3-phenyl-1-propanamine;hydrochloride,
A-7328,
N-methyl-3-phenyl-propan-1-amine;hydrochloride,
I05-2014,
J-015154,
F2167-1305,
Fluoxetine Related Compound B, United States Pharmacopeia (USP) Reference Standard,
Phenylpropylmethylamine,
METHYL- -AMINE,
C10H15N,
CID35417,
NSC53657,
N-methyl-3-phenylpropan-1-amine;hydrochloride,